Yes. It was a SEC Letter. I was clear on that. FDA has no jurisdiction on comuniques done by companies to markets, this is a SEC regulatory field.
The SEC WARNED bioscam company NANOVIRICIDES to ONLY "discuss the objective results of your pre-clinical and clinical trials without concluding that such results demonstrate that your product candidates are safe or effective". Conclusion within the SOLE AUTHORITY of the FDA and comparable foreign regulators.
Note that (nowadays) "comparable regulators" may not be INDIA or CHINA, since quality of data and procedures from foreign countries is being questioned RIGHT NOW by US Congress. Which indeed is a rightful move and things must be corrected before great human life losses befal, just for lack of oversight and the correct application of our western standards.